THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
DAVID BOOTHMAN,JINMING GAO,ERIK BEY,YING DONG
申请号：
PT11827555
公开号：
PT2619331T
申请日:
2011.09.22
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
Disclosed herein are methods for determining whether an individual with cancer is suitable for a treatment with an NQO1 bioactivatable drug, predicting responsiveness of an individual with cancer to a treatment with an NQO1 bioactivatable drug, and treating an individual with cancer with an NQO1 bioactivatable drug composition.
